Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 24667281)

1.

Β-adrenergic blockade combined with subcutaneous B-type natriuretic peptide: a promising approach to reduce ventricular arrhythmia in heart failure?

Thireau J, Karam S, Roberge S, Roussel J, Aimond F, Cassan C, Gac A, Babuty D, Le Guennec JY, Lacampagne A, Fauconnier J, Richard S.

Heart. 2014 Jun;100(11):833-41. doi: 10.1136/heartjnl-2013-305167. Epub 2014 Mar 25.

PMID:
24667281
2.

Efficacy of B-Type Natriuretic Peptide Is Coupled to Phosphodiesterase 2A in Cardiac Sympathetic Neurons.

Li D, Lu CJ, Hao G, Wright H, Woodward L, Liu K, Vergari E, Surdo NC, Herring N, Zaccolo M, Paterson DJ.

Hypertension. 2015 Jul;66(1):190-8. doi: 10.1161/HYPERTENSIONAHA.114.05054. Epub 2015 Apr 27.

3.

Republished: A straightforward guide to the basic science behind arrhythmogenesis.

Dumotier BM.

Postgrad Med J. 2015 Apr;91(1074):221-9. doi: 10.1136/postgradmedj-2014-305647rep. Review.

PMID:
25862707
5.

Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.

Rinaldi B, Donniacuo M, Sodano L, Gritti G, Martuscelli E, Orlandi A, Rafaniello C, Rossi F, Calzetta L, Capuano A, Matera MG.

Br J Pharmacol. 2015 Jul;172(14):3627-37. doi: 10.1111/bph.13148. Epub 2015 May 12.

PMID:
25825265
6.

MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.

Tang Y, Wang Y, Park KM, Hu Q, Teoh JP, Broskova Z, Ranganathan P, Jayakumar C, Li J, Su H, Tang Y, Ramesh G, Kim IM.

Cardiovasc Res. 2015 Jun 1;106(3):387-97. doi: 10.1093/cvr/cvv121. Epub 2015 Mar 30.

PMID:
25824147
7.

Novel receptor-derived cyclopeptides to treat heart failure caused by anti-β1-adrenoceptor antibodies in a human-analogous rat model.

Boivin V, Beyersdorf N, Palm D, Nikolaev VO, Schlipp A, Müller J, Schmidt D, Kocoski V, Kerkau T, Hünig T, Ertl G, Lohse MJ, Jahns R.

PLoS One. 2015 Feb 20;10(2):e0117589. doi: 10.1371/journal.pone.0117589. eCollection 2015.

8.

Arrhythmogenic remodeling of β2 versus β1 adrenergic signaling in the human failing heart.

Lang D, Holzem K, Kang C, Xiao M, Hwang HJ, Ewald GA, Yamada KA, Efimov IR.

Circ Arrhythm Electrophysiol. 2015 Apr;8(2):409-19. doi: 10.1161/CIRCEP.114.002065. Epub 2015 Feb 11.

PMID:
25673629
9.

Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.

Bielmann C, Rignault-Clerc S, Liaudet L, Li F, Kunieda T, Sogawa C, Zehnder T, Waeber B, Feihl F, Rosenblatt-Velin N.

Basic Res Cardiol. 2015 Jan;110(1):455. doi: 10.1007/s00395-014-0455-4. Epub 2014 Dec 2.

PMID:
25449896
10.

Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?

Gerdes AM.

Am J Physiol Heart Circ Physiol. 2015 Jan 1;308(1):H1-10. doi: 10.1152/ajpheart.00704.2014. Epub 2014 Nov 7. Review.

PMID:
25380818
11.

Insights into the clinical implications of carbohydrate antigen 125 as a biomarker of heart failure: a meta-analysis and systematic review of published studies.

Zhuang J, Faggiano P, Li Q, Pradelli D, Med V, Peng W, Zuo M, Xu Y.

J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):864-72. doi: 10.2459/JCM.0000000000000051. Review.

PMID:
25353973
12.

Impact of combined clenbuterol and metoprolol therapy on reverse remodelling during mechanical unloading.

Navaratnarajah M, Siedlecka U, Ibrahim M, van Doorn C, Soppa G, Gandhi A, Shah A, Kukadia P, Yacoub MH, Terracciano CM.

PLoS One. 2014 Sep 30;9(9):e92909. doi: 10.1371/journal.pone.0092909. eCollection 2014.

13.

S100A1: a major player in cardiovascular performance.

Duarte-Costa S, Castro-Ferreira R, Neves JS, Leite-Moreira AF.

Physiol Res. 2014;63(6):669-81. Epub 2014 Aug 26.

14.

Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.

Yamada Y, Kinoshita H, Kuwahara K, Nakagawa Y, Kuwabara Y, Minami T, Yamada C, Shibata J, Nakao K, Cho K, Arai Y, Yasuno S, Nishikimi T, Ueshima K, Kamakura S, Nishida M, Kiyonaka S, Mori Y, Kimura T, Kangawa K, Nakao K.

Cardiovasc Res. 2014 Oct 1;104(1):183-93. doi: 10.1093/cvr/cvu185. Epub 2014 Aug 5.

PMID:
25100767
15.
16.

ROSE-AHF and lessons learned.

Jain AK, Chen HH.

Curr Heart Fail Rep. 2014 Sep;11(3):260-5. doi: 10.1007/s11897-014-0208-6. Review.

PMID:
24966060
17.

Heartbeat: highlights from the issue.

Kirchhof P, Otto CM.

Heart. 2014 Jun;100(11):817-8. doi: 10.1136/heartjnl-2014-306041. No abstract available.

PMID:
24812143
18.

Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response.

Zatarain-Nicolás E, de la Fuente-Galán L, San Román-Calvar JA.

Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):242. doi: 10.1016/j.rec.2013.11.006. Epub 2014 Feb 5. No abstract available.

PMID:
24774407
19.

Home subcutaneous infusion of furosemide in advanced decompensated heart failure.

Sancho-Zamora MA.

Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):241-2. doi: 10.1016/j.rec.2013.10.007. Epub 2014 Feb 1. No abstract available.

PMID:
24774406
20.

Subcutaneous infusion of furosemide administered by elastomeric pumps for decompensated heart failure treatment: initial experience.

Zatarain-Nicolás E, López-Díaz J, de la Fuente-Galán L, García-Pardo H, Recio-Platero A, San Román-Calvar JA.

Rev Esp Cardiol (Engl Ed). 2013 Dec;66(12):1002-4. doi: 10.1016/j.rec.2013.06.008. Epub 2013 Sep 17. No abstract available.

PMID:
24774118
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk